TINN2 is a European research network (Collaborative Project) supported by the European Commission under the Health Cooperation Work Programme of the 7 th Framework Programme.

News & Events


TINN European Survey on the Use of Antibiotics in NICUs

The survey results are now available and the published article has been published.

Please click here to consult it.


MANY THANKS to all the Neonatal Intensive Care Units that dedicated their time to partipate in the TINN2 survey.


Consortium final meeting on 8th October 2015, in Paris, France

The official event of the TINN2 FP7 European Research Project was organised by Inserm-Transfert on 8th October 2015 in Paris (France).

This meeting gathered together all TINN2 partners for presenting and discussing the latest progresses within TINN2 activities, a project on preclinical studies and paediatric investigation plans for children, under the coordination of the French National Institute of Health and Medical Research (Inserm).

European Congress of Clinical Microbiology and Infectious Diseases, London, United Kingdom 31st to 4th April 2012


TINN2 Project was presented on Poster at the ECCMID congress in London, United Kingdom.

Brochure PDF :

Cardiff University

Cardiff University is one of Britain's leading teaching and research universities. With c. 26,000 students and c. 6,000 staff, the Cardiff University academic community is the size of a small town. It is a community with an annual turnover of £370 million. Research is undertaken in each of the 28 Schools, and at any one time there are more than 1,000 research contracts in operation. Some 7,000 students graduate each year.

The Department of Child Health has a strong record of clinical trials in paediatrics and currently leads several multicentre randomised controlled clinical trials: Use of magnesium sulphate in acute asthma (MAGNETIC), Hospital vs. Home Treatment of diabetes ketoacidosis (DECIDE), motivational interviewing for children with diabetes (DEPICTED), research into child protection (PROTECT), amongst others with an annual turnover of over £2 million per year. My research group has a strong interest in the pathogenesis of chronic lung disease of prematurity. Together with two senior lecturers, Dr Brad Spiller and Dr Colin Powell; Dr Eamon McGreal lecturer, and a new professorial position, our work investigates the underlying causes of lung disease in newborn babies, in particular the role of ante- and post-natal infection and host innate immunity responses to such infections. We have developed the methodology for a pragmatic clinical trial to assess the use of azithromycin for clinical indications which should lead to the award of a PUMA for this drug.

Besides previous experience in participating in clinical trials for neonatal conditions (use of ECMO, intravenous immunoglobulins, use of nitric oxide), Professor Sailesh Kotecha has been a member of steering committees of such trials and have chaired data monitoring committees. I lead the Wales Children’s Research Network and of the All Wales Perinatal Survey (-a clinical database of mortality in newborn infants); and am on the steering committee of the Wales Paediatric Surveillance Unit which surveys rare diseases in Wales. In addition, we have set up the relevant methodology for identifying Ureaplasma and for identifying antibiotic resistance to Ureaplasma. I am a clinical neonatologist with an interest in respiratory diseases working in the largest centre in Wales and one of the largest in the UK.


Back to the list of institutions